Zhang, Si <br/><br/>
BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism.  [electronic resource] 

 -  Thrombosis and haemostasis  Oct 2010 
 - 845-57 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH10-05-0285  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--administration & dosage<br/>Adenosine Monophosphate--analogs & derivatives<br/>Adenosine Triphosphate--biosynthesis<br/>Animals<br/>Blood Platelets--drug effects<br/>CHO Cells<br/>Coronary Artery Disease--drug therapy<br/>Cricetinae<br/>Cricetulus<br/>Humans<br/>Mice<br/>Mice, Knockout<br/>Phosphoric Diester Hydrolases--genetics<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Purinergic P2Y Receptor Antagonists--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Purinergic P2Y12--genetics